TYPE-III HYPERLIPOPROTEINEMIA AND RENAL-DISEASE

Citation
G. Feussner et al., TYPE-III HYPERLIPOPROTEINEMIA AND RENAL-DISEASE, NMCD. Nutrition Metabolism and Cardiovascular Diseases, 4(2), 1994, pp. 96-100
Citations number
NO
Categorie Soggetti
Cardiac & Cardiovascular System","Endocrynology & Metabolism","Nutrition & Dietetics
ISSN journal
09394753
Volume
4
Issue
2
Year of publication
1994
Pages
96 - 100
Database
ISI
SICI code
0939-4753(1994)4:2<96:THAR>2.0.ZU;2-T
Abstract
Twelve patients (seven women and five men) were identified with chroni c renal disease and homozygosity for apolipoprotein (apo) E2. All subj ects were shown to have dysbetalipoproteinemia (an elevated ratio of v ery-low-density lipoprotein cholesterol to serum triglycerides, i.e., >0.3) and/or type III hyperlipoproteinemia (HLP). The causes of the re nal disease were heterogeneous and no significant correlations could b e shown between lipid levels and age of the patients, duration of the renal disease, or maintenance hemodialysis. However, renal disease see ms to be one of the factors influencing the phenotypic expression of t ype III HLP in genetically predisposed individuals. Hence, apo E2 homo zygotes with renal disease might be particularly prone to the developm ent of hyperlipidemia, and thus accelerated atherosclerosis.